In preclinical research, all‐trans retinoic acid (ATRA) and CD38 CAR‐T cells were coupled to treat AML cell lines, and increased CD38 expression strengthened the cytotoxic effect on AML cell lines.63, 64. This evidence concerns the gene CD38 and acute myeloid leukemia.